Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus tranexamic acid plus ethamsylate for reducing intraoperative bleeding during abdominal myomectomy
PACTR202008739887429Unknown
- Sponsor
- Elgalaa Teaching Hospital
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of oxytocin, tranexamic acid and etamsylate in Fibromyoma (LM) (3 arms), sponsored by Elgalaa Teaching Hospital. Primary endpoint: Amount of blood loss. Status: unknown.
02
Drugs
oxytocintranexamic acidetamsylate
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202008739887429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008739887429.